# A Single Center, Open-Label Study to Quantify Metabolites of [14C]-Neramexane in Plasma and Urine in Healthy Male Subjects

> **NCT01109680** · PHASE1 · COMPLETED · sponsor: **Merz Pharmaceuticals GmbH** · enrollment: 8 (estimated)

## Conditions studied

- Metabolism of Neramexane

## Interventions

- **DRUG:** Neramexane

## Key facts

- **NCT ID:** NCT01109680
- **Lead sponsor:** Merz Pharmaceuticals GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2011-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01109680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01109680, "A Single Center, Open-Label Study to Quantify Metabolites of [14C]-Neramexane in Plasma and Urine in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01109680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*